Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs143420457 | chr1:220264377 | C/T | 4.25E-5 | 481 | 31.23 | 24.9 | 39.5 | KM Plot |
PRAD | rs143475983 | chr3:14037470 | GTTCA/G | 0.00014 | 492 | 30.77 | 31.37 | 21.58 | KM Plot |
PRAD | rs143541793 | chr2:107435807 | GA/G | 1.57E-5 | 488 | 30.87 | 30.7 | 32.63 | KM Plot |
PRAD | rs143599191 | chr11:36308862 | T/C | 8.91E-5 | 481 | 30.8 | 32.43 | 27.57 | KM Plot |
PRAD | rs143878816 | chr7:135104004 | CCTATT/C | 2.14E-9 | 490 | 30.8 | 31.9 | 3.03 | KM Plot |
PRAD | rs143927632 | chr5:154161149 | G/A | 0 | 491 | 30.2 | 33.47 | 4.87 | KM Plot |
PRAD | rs144146238 | chr9:72914573 | TC/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
PRAD | rs144219745 | chr11:6930651 | C/G | 1.47E-12 | 492 | 31 | 28.67 | 18.13 | KM Plot |
PRAD | rs144312087 | chr19:53133601 | G/A | 4.35E-6 | 488 | 30.8 | 31.18 | 26.27 | KM Plot |
PRAD | rs144415248 | chr9:72945573 | C/A | 1.75E-5 | 492 | 30.8 | 31.4 | 22.45 | KM Plot |
PRAD | rs144548059 | chr22:18480841 | G/GTGAA | 3.13E-8 | 480 | 30.27 | 31.87 | 27.83 | KM Plot |
PRAD | rs144688912 | chr19:45470192 | A/G | 4.82E-5 | 487 | 30.33 | 30.9 | 45.2 | KM Plot |
PRAD | rs144711443 | chr5:154272657 | A/AAAAC | 0 | 494 | 30.2 | 33.47 | 5.58 | KM Plot |
PRAD | rs144711450 | chr9:72849262 | A/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
PRAD | rs144731924 | chr9:72868615 | G/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |